Literature DB >> 22241720

The role of fibroblast growth factor receptor 4 overexpression and gene amplification as prognostic markers in pediatric and adult adrenocortical tumors.

Luciana Pinto Brito, Tamaya Castro Ribeiro, Madson Q Almeida, Alexander Augusto de Lima Jorge, Iberê Cauduro Soares, Ana Claudia Latronico, Berenice Bilharinho Mendonca, Maria Candida Barisson Villares Fragoso, Antonio Marcondes Lerario.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22241720     DOI: 10.1530/ERC-11-0231

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  12 in total

Review 1.  Genetics of Adrenocortical Development and Tumors.

Authors:  Maya Lodish
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-22       Impact factor: 4.741

Review 2.  Regulation of the adrenocortical stem cell niche: implications for disease.

Authors:  Elisabeth M Walczak; Gary D Hammer
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

3.  Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.

Authors:  Hao Chen; Dan-Ping Shen; Zi-Zhen Zhang; Jia-Hua Liu; Yan-Ying Shen; Xing-Zhi Ni
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

4.  Targeted genomic analysis of 364 adrenocortical carcinomas.

Authors:  Nikita Pozdeyev; Lauren Fishbein; Laurie M Gay; Ethan S Sokol; Ryan Hartmaier; Jeffrey S Ross; Sourat Darabi; Michael J Demeure; Adwitiya Kar; Lindsey J Foust; Katrina Koc; Daniel W Bowles; Stephen Leong; Margaret E Wierman; Katja Kiseljak-Vassiliades
Journal:  Endocr Relat Cancer       Date:  2021-08-16       Impact factor: 5.900

Review 5.  Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.

Authors:  Morgan K Penny; Isabella Finco; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2016-12-08       Impact factor: 4.102

Review 6.  The Fibroblast Growth Factor signaling pathway.

Authors:  David M Ornitz; Nobuyuki Itoh
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-03-13       Impact factor: 5.814

Review 7.  The challenge of developmental therapeutics for adrenocortical carcinoma.

Authors:  Ricardo Costa; Benedito A Carneiro; Fabio Tavora; Sachin G Pai; Jason B Kaplan; Young Kwang Chae; Sunandana Chandra; Peter A Kopp; Francis J Giles
Journal:  Oncotarget       Date:  2016-07-19

8.  Stemness regulation of the adrenal mixed corticomedullary tumorigenesis-a case-control study.

Authors:  Hsin-Ying Clair Chiou; He-Jiun Jiang; Sheau-Fang Yang; Kung-Kai Kuo; Pi-Chen Lin; Pi-Jung Hsiao
Journal:  Neoplasia       Date:  2020-05-18       Impact factor: 5.715

Review 9.  Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Authors:  Harriet R Ferguson; Michael P Smith; Chiara Francavilla
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

10.  Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.

Authors:  Sara Bedrose; Kevin Charles Miller; Lina Altameemi; Mohamed S Ali; Sameh Nassar; Naveen Garg; Marilyne Daher; Keith D Eaton; Jeffrey Thomas Yorio; Davey B Daniel; Matthew Campbell; Keith C Bible; Mabel Ryder; Ashish V Chintakuntlawar; Mouhammed Amir Habra
Journal:  J Immunother Cancer       Date:  2020-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.